Biotech Innovations: From AI to Bio-Agriculture ⸺ Hong Kong's Path Towards a Biotech Hub (Session 1&2)
Biotech Innovations: From AI to Bio-Agriculture ⸺ Hong Kong's Path Towards a Biotech Hub (Session 1&2)
團結香港基金（基金會）日前舉辦了「團結卓爾論壇」新經濟系列，以「Biotech Innovations: From AI to Bio-Agriculture — Hong Kong’s Path Towards a Biotech Hub」為題，深入探討如何運用人工智能推動藥物研發。
論壇邀得新元資本創始人及高級合夥人宋紅方女士為主講嘉賓，演講分為兩節，內容包括人工智能助力微創醫療，及革新兼具快捷與智能化的救生診斷技術。宋紅方女士表示：「傳統藥物開發失敗率高達95%及造成每年600億美元浪費，透過新元資本專屬AI平台『ORIzon』，從患者需求出發，優化靶點識別、分子構建及臨床試驗，縮短開發時程40至60%、降低540億美元研發成本，並增加16.7%成功率。」
是次分享會座無虛席，獲各行各業的企業高管、行業翹楚參與以及各界大力支持；同系列主題的第二場論壇將於11月14日舉行。
Join us for a thought-provoking two-day Insight Forum, partnering with ORI Capital and featuring renowned biotech leader, Simone Song, Founder and Senior Partner of ORI Capital. The forum will explore how AI can be harnessed to advance innovation in drug development, diagnostics, MedTech, bio-agriculture and beyond.
Don’t miss this unique opportunity to engage with industry experts and discover actionable strategies that will shape the future of biotech in Hong Kong and beyond. Whether you are a biotech strategist, healthcare practitioner, policymaker, or innovation enthusiast, this series will equip you with the knowledge and networks needed to accelerate progress in Hong Kong’s vibrant biotech ecosystem.
Join all sessions to receive a Certificate of Attendance, acknowledging your full commitment and active participation.
團結香港基金（基金會）日前舉辦了「團結卓爾論壇」新經濟系列，以「Biotech Innovations: From AI to Bio-Agriculture — Hong Kong’s Path Towards a Biotech Hub」為題，深入探討如何運用人工智能推動藥物研發。
論壇邀得新元資本創始人及高級合夥人宋紅方女士為主講嘉賓，演講分為兩節，內容包括人工智能助力微創醫療，及革新兼具快捷與智能化的救生診斷技術。宋紅方女士表示：「傳統藥物開發失敗率高達95%及造成每年600億美元浪費，透過新元資本專屬AI平台『ORIzon』，從患者需求出發，優化靶點識別、分子構建及臨床試驗，縮短開發時程40至60%、降低540億美元研發成本，並增加16.7%成功率。」
是次分享會座無虛席，獲各行各業的企業高管、行業翹楚參與以及各界大力支持；同系列主題的第二場論壇將於11月14日舉行。
Join us for a thought-provoking two-day Insight Forum, partnering with ORI Capital and featuring renowned biotech leader, Simone Song, Founder and Senior Partner of ORI Capital. The forum will explore how AI can be harnessed to advance innovation in drug development, diagnostics, MedTech, bio-agriculture and beyond.
Don’t miss this unique opportunity to engage with industry experts and discover actionable strategies that will shape the future of biotech in Hong Kong and beyond. Whether you are a biotech strategist, healthcare practitioner, policymaker, or innovation enthusiast, this series will equip you with the knowledge and networks needed to accelerate progress in Hong Kong’s vibrant biotech ecosystem.
Join all sessions to receive a Certificate of Attendance, acknowledging your full commitment and active participation.
